page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Mefloquine (Larium)

Category:

  • Antimalarial

Description:

  • Quinine structural analog

Indications:

  • P. falciparum and P. vivax malaria acute treatment

  • P. falciparum and P. vivax malaria prophylaxis

  • Chloroquine-resistant malaria prophylaxis

Contraindications:

Precautions:

  • Pregnancy category C

  • Do not take on an empty stomach.

  • Drink at minimum of 240mL (8 ounces) of water with each dose.

  • Patients administered mefloquine for acute malaria attack have high relapse rate, therefore also dose with primaquine.

Adverse Reactions (Side Effects):

  • Vomiting (3%)

  • Dizziness, syncope, hallucinations, visual changes

Dosage:

  • Administered orally

  • Acute attack:

    • 5 tablets (1250mg) as a single, one time dose

  • Prophylaxis:

    • Initiate therapy one week prior to arriving in area, during stay in area and four weeks after leaving area

    • Adult: 250mg every week for 4 weeks, then 250mg every other week thereafter.

    • Children (dosing by weight):

      • 16-19kg: 62.5mg (¼ tablet)

      • 20-30kg: 125mg (½ tablet)

      • 31-45kg: 187.5mg (¾ tablet)

      • >45kg: 250mg

 

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site